• Patients & Caregivers

BrainWeb

BrainWeb provides information and links to validated sites about brain diseases and disorders from outside sources and from Dana publications.

 

Staying Sharp 

The Dana Alliance for Brain Initiatives' Staying Sharp program includes live public forums, printed and printable resources, and videos.

Reports on Progress

Reviews by eminent neuroscientists of specific areas of research, including normal function, disease, and new technologies. 

Briefing Papers

Briefing Papers take an in-depth look at basic and timely brain-related topics, like traumatic brain injury and obesity.


Recent Articles 

 

The Link Between Depression, Sleep, and Stress

 Researchers discussed the molecular mechanisms linking sleep to depression and stress at the 9th FENS Forum of Neuroscience in Milan last month.



Closing the Gap Between Cochlear Implants and Natural Hearing

Approaches include stimulating the growth of nerve fibers to improve sound perception and scanning the cortex to improve the device’s programming.



Can Hearing Loss Predict—or Lead to—Cognitive Decline?

Possible links between impaired hearing and loss of cognitive abilities raise the tantalizing possibility that restoring hearing could slow cognitive decline.



Beyond Serotonin: Depression at the microRNA Level

Researchers focusing on glutamate pathways may have found a potential biomarker for the mood disorder.



Patterning the Brain

Molecular neurobiologist Dennis O'Leary described his work during a special lecture after being awarded the European Dana Alliance for the Brain (EDAB)/ Max Cowan Prize at the 9th FENS Forum of Neuroscience.



Stem Cell Transplants Show Promise for Future Parkinson’s Treatments

Stem Cell Transplants Show Promise for Future Parkinson’s Treatments 2014-07-24 Parkinson's disease is a debilitating neurodegenerative disorder that targets dopaminergic cells in an area of the brain called the substantia nigra. Most patients are treated with the drug Levodop



An Antidepressant to Prevent Alzheimer’s?

Scientists report promising results from a small clinical trial of an SSRI drug to lower amyloid beta levels, but years of further tests lie ahead.



How Far Should Brain Researchers Go?

How much should we enhance our brains, how far should we go to treat risky pre-term pregnancies, and when can we morally do research on people having surgery for something else were among the topics at the William Safire Seminar on Neuroethics.



Obesity Linked to Changes in Brain’s White Matter Structure—and Cognition

Reducing fat levels in obese mice through exercise or surgery appears to result in better cognitive performance.